KLI

Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes

Metadata Downloads
Abstract
To maintain normal glucose homeostasis after a meal, it is essential to secrete an adequate amount of insulin from pancreatic β-cells. However, if pancreatic β-cells solely depended on the blood glucose level for insulin secretion, a surge in blood glucose levels would be inevitable after the ingestion of a large amount of carbohydrates. To avoid a deluge of glucose in the bloodstream after a large carbohydrate- rich meal, enteroendocrine cells detect the amount of nutrient absorption from the gut lumen and secrete incretin hormones at scale. Since insulin secretion in response to incretin hormones occurs only in a hyperglycemic milieu, pancreatic β-cells can secrete a “Goldilocks” amount of insulin (i.e., not too much and not too little) to keep the blood glucose level in the normal range. In this regard, pancreatic β-cell sensitivity to glucose and incretin hormones is crucial for maintaining normal glucose homeostasis. In this Namgok lecture 2022, we review the effects of current anti-diabetic medications on pancreatic β-cell sensitivity to glucose and incretin hormones.
Issued Date
2023
Chang Ho Ahn
Tae Jung Oh
Se Hee Min
Young Min Cho
Type
Article
Keyword
IncretinsInsulin-secreting cellsGlucagon-like peptide 1Glucose-dependent insulinotropic polypeptideDiabetes mellitustype 2
DOI
10.3803/EnM.2023.103
URI
https://oak.ulsan.ac.kr/handle/2021.oak/16110
Publisher
Endocrinology and Metabolism
Language
한국어
ISSN
2093-596X
Citation Volume
38
Citation Number
1
Citation Start Page
1
Citation End Page
9
Appears in Collections:
Medicine > Nursing
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.